Pérez RM

Language: Spanish
References: 10
Page: 91-93
PDF size: 112.64 Kb.

Text Extraction

No Abstract

REFERENCES

1. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004;64:631-649.

2. de Vries RR. HLA and disease: past, present and future. Neth J Med 1994;45(6):302-308.

3. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997;53 (1):1-11.

4. Svejgaard A, Platz P, Ryder LP. HLA and disease 1982--a survey. Immunol Rev 1983;70:193-218.

5. Batchelor JR, McMichael AJ. Progress in understanding HLA and disease associations. Br Med Bull 1987;43(1):156-183.

6. Lechler R. Mechanisms of HLA and disease associations. En: Lechler R, editor. Lechler HLA and disease. London, UK: Academic Press Limited; 1994. p. 83-91.

7. Heard R. HLA and autoimmune disease. En: Lechler R, editor. Lechler: HLA and disease. London, UK: Academic Press Limited; 1994. p. 123-151.

8. Chang CC, Campoli M, Ferrone S. HLA class I defects in malignant lesions: What have we learned? Keio J Med 2003;52(4) 220-229.

9. Andersson M, Paabo S, Nilsson T, Peterson PA. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 1985;43(1):215-222.

10. Logunova NN, Viret C, Pobezinsky LA, Miller SA, Kazansky DB, Sundberg JP, et al. Restricted MHC-peptide repertoire predisposes to autoimmunity. JEM 2005; 202(1):73-84.